CELL LINES, COMPOSITIONS CONTAINING THEM FOR TREATMENT OF MELANOMAS, METHODS FOR PRODUCTION OF COMPOSITIONS AND METHODS OF TREATMENT Russian patent published in 2013 - IPC C12N5/09 C12N5/784 A61K48/00 A61P35/00 A61P37/00 

FIELD: biotechnologies.

SUBSTANCE: cell lines of human melanoma, such as Mel-XYl, deposited in DSMZ under No. DSM ACC2830, Mel-XY2, deposited in DSMZ under No. DSM ACC2831, Mel-XY3, deposited in DSMZ under No. DSM ACC2832, and Mel-XX4, deposited in DSMZ under No. DSM ACC2829, are radiated to produce populations with apoptotic and necrotic phenotype. The produced cell lines are used in various combinations for treatment of malignant diseases, namely, for treatment of human melanoma. Also the specified populations of radiated cells are cocultivated with autological dendrite cells for further joint injection to a patient suffering from melanoma.

EFFECT: invention makes it possible to induce a resistant anti-cancer immune response in a mammal suffering from melanoma.

21 cl, 10 dwg, 4 tbl, 5 ex